Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2023 | 06-2022 | 06-2021 | 06-2020 | 06-2019 | |
| Operating Expenses | 6,274 | 7,618 | 1,381 | 812 | 391 |
| Operating Income | -6,274 | -7,618 | -1,381 | -812 | -391 |
| Other Income | 211 | 23 | 35 | 0 | 0 |
| Pre-tax Income | -6,062 | -7,595 | -1,347 | -812 | -391 |
| Net Income Continuous | -6,062 | -7,595 | -1,347 | -812 | -391 |
| Minority Interests | -191 | -149 | N/A | N/A | N/A |
| Net Income | $-5,871 | $-7,446 | $-1,347 | $-812 | $-391 |
| EPS Basic Total Ops | -0.45 | -0.58 | -0.13 | -0.08 | -0.04 |
| EPS Basic Continuous Ops | -0.47 | -0.59 | -0.13 | -0.08 | -0.04 |
| EPS Diluted Total Ops | -0.45 | -0.58 | -0.13 | -0.08 | -0.04 |
| EPS Diluted Continuous Ops | -0.47 | -0.59 | -0.13 | -0.08 | -0.04 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.58 | N/A | N/A | N/A |
| EBITDA(a) | $-5,981 | $-7,468 | $-1,355 | $-803 | $-391 |